KKR completed the acquisition of a majority stake in HealthCare Royalty Partners.

KKR, a global investment firm, completed the acquisition of a majority stake in HealthCare Royalty Partners, a biopharma royalty acquisition company. Financial terms were not disclosed. “Joining forces with KKR marks a significant milestone for HCRx. We share a common vision of supporting the growth and innovation of the biopharma industry. With KKR’s resources, expertise and similar approach to partnership, we are well positioned to scale our platform, more comprehensively serve the landscape of biopharma companies and continue delivering value to our stakeholders,” Clarke Futch, HealthCare Royalty Partners Chairman and CEO.